May 1, 2026: GLP-1 Litigation Cases Increase As Studies Examine Other Possible Ozempic Side Effects As of May 1, 2026, there are a total of 3,636 lawsuits that have been filed or transferred into the consolidated MDL against companies that make Ozempic and other GLP-1s
Glucose intolerance and, rarely, benign intracranial hypertension have also been reported
These findings provide in vitro evidence of a causal link through which the HIF-1/ROS (H 2 O 2 )/JAK/STAT3 axis promotes HGSOC progression (29)
the exact mechanism of their carcinogenicity is not completely understood, although many are weak mutagens (cause DNA damage), can disrupt gene expression, and deregulate cell growth and development
Left thigh one week, right thigh the next, is a legitimate rotation
Protopapas N, Hamilton LE, Warkentin R et al (2019) The perforatorium and postacrosomal sheath of rat spermatozoa share common developmental origins and protein constituents